Efficacy of donepezil on cognitive functions in mild cognitive impairment

Klinik Psikofarmakoloji Bulteni

Volumn 17, Issue 2, 2007, Pages 62-67

  Özenli, Yarkin ^a   Yaǧci, Didem ^a   Karaca, Sibel ^b  

^a BASKENT UNIVERSITY   (Turkey)

^b Izzet Baysal Üniversitesi   (Turkey)

Author keywords

Cognitive functions; Donepezil; MCI; WMRS R

Indexed keywords

DONEPEZIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALE; MEMORY; NAUSEA; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; VERBAL MEMORY; VOMITING; WECHSLER MEMORY SCALE;

EID: 34347383813     PISSN: 10177833     EISSN: 13029657     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Ritchie K, Touchon J. Mild cognitive impairment: conceptual basis and current nosological status. Lancet 2000; 355: 225-228.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994
3. Kaplan HI, Sadock BJ (editors) Geriatric Psychiatry. In Synopsis of psychiatry. ed. Baltimore: Williams & Wilkins, 1998: pp.1289-130.
4. Salloway S, Ferris S, Kluger A, Goldman R, Griesing T. Efficacy of donepezil in mild cognitive impairment: A randomized placebo-controlled trial. Neurology 2004; 63:651-657.
5. Winblad B, Palmer K, Kivipelto M, Jelic V. Mild Cognitive Impairment- beyond controversies, towards a consensus: Report of the international working group on Mild Cognitive Impairment. J Intern Med 2004; 256: 240-246.
6. Rubin EH, Morris JC, Grant EA. Very mild senile dementia of the Alzheimer type. I. Clinical assessment. Arch Neurol 1989; 46:379-382.
7. Petersen RC, Smith GE, Waring SC, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-308.
8. Petersen RC, Doody R, Kurz A, Tangalos EG. Current conception mild cognitive impairment. Arch Neurol 2001; 58:1985-1992.
9. Tune L, Tiseo PJ, Ieni J, Perdomo C, Pradd RD. Donepezil HCl maintains functional Brain activity in patients with Alzheimer Disease. Am J Geriatr Psychiatry 2003;11: 169-177.
10. Wolf H, Grunwald M, Ecke G. The prognosis of mild cognitive impairment in the elderly. J Neurol Transm Suppl 1998; 54: 31-50.
11. Winblad B,Engedal K, Soininen H, Verhey F, Waldemar G, Wimo A, Wetterholm. A. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology 2001; 57: 489-495.
12. Wechsler D. WMS-R: Wechsler Memory Scale-Revised (The psychologic corporation). New York: Harcourt, Brace Jovanovich, 1987.
13. Karakaş S, Kafadar H, Eski R. The test-retest reliability of WMS-R. Türk Psikoloji Dergisi 1996; 11: 46-52.
14. Folstein MF, Folstein SE, Mchugh PR. Mini mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 66: 189-198.
15. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62.
16. Daly E, Zaitchic D, Copeland M. Predicting conversion to Alzheimer disease using standardized clinical information. Arch Neurol 2000; 57: 675-680.
17. Kluger A, Ferris SH, Golomb J. Neuropsychological prediction of decline to dementia in non demented elderly. J Geriatr Psychiatr Neurol 1999;12: 168-179.
18. Bowen J, Teri L, Kukull W. Progression to dementia in patients with isolated memory loss. Lancet 1997; 349:763-765.
19. Ritchie K, Ledesert B, Touchon J. Subclinical cognitive impairment: epidemiology and clinical characteristics. Compr Psychiatry 2000; 41:61-65.
20. Masur DM, Sliwinski M, Lipton RB, Blau AD, Crystal HA. Neuropsychological prediction of dementia and the absence demantia in healthy elderly persons. Neurology 1994; 44: 1427-1432.
21. Saykin AJ, Wishart HA, Rabin LA, Flashman LA, Mchugh TL, Mamourian AC, Santulli RB. Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. Brain 2004; 127:1574-1583.
22. Rodriguez G, Vitali P, Canfora M, Calvini P, Girtler N, De Leo C, Piccardo A, Nobili F. Quantitative EEG and perfusional single photon emision computed tomography correlation during long term donepezil therapy in Alzheimer disease. Clin Neurophysiol 2004; 115: 39-49.
23. Nobili F, Vitali P, Canfora M, Girtler N, De Leo C, Mariani G, Pupi A, Rodriguez G. Effect of long-term donepezil therapy on rCBF of Alzheimer patients. Clin Neurophysiol 2002; 113: 1241-1248.
24. Shinotoh H, Aotsuka A, Fukushi K, Nagatsuka S, Tanaka N, Ota T, Tanada S, Irie T. Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET. Neurology 2001; 56: 408-410.
25. Rocco P, Cocuzza E, Marchiaro L, Bogetto F. Rocco P, Cocuzza E, Marchiaro L. Donepezil in treatment alzheimer disease long-term efficacy and safety. Progr Neuro-Psychopharmacol Biol Psychiatry.2002;26: 369-373.
26. Nakano S, Takashi H, Madsuda H, Uno M, Takasaki M. Donepezil Hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease. J Nucl Med 2001; 42: 1441-1445.
27. Krishnan KR, Charles HC, Doraiswamy PM, Mintzer J, Weisler R, Yu Xin Perdomo C, Ieni JR, Rogers S. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in alzheimer's disease. Am J Psychiatry 2003;160: 2003-2011.